Baseline characteristics of the study population
| All Patients (N = 46) | Patients with Acute Reocclusion (n = 6) | Patients without Acute Reocclusion (n = 40) | P Value | |
|---|---|---|---|---|
| Age (yr) (IQR) | 66 (57.75–74.75) | 63 (57.5–72.5) | 66 (57.5–76.25) | NS |
| Male sex (No.) (%) | 28 (60.9) | 3 (50) | 25 (62.5) | NS |
| Risk factors (No.) (%) | ||||
| Hypertension | 29 (63) | 4 (66.7) | 25 (62.5) | NS |
| Diabetes mellitus | 20 (43.6) | 2 (33.3) | 18 (45) | NS |
| Dyslipidemia | 26 (56.5) | 4 (66.7) | 22 (55) | NS |
| Smoking | 10 (21.7) | 2 (33.3) | 8 (20) | NS |
| Atrial fibrillation | 4 (8.7) | 0 (0) | 4 (10) | NS |
| Previous CAD | 1 (2.2) | 0 (0) | 1 (2.5) | NS |
| Congestive heart failure | 1 (2.2) | 0 (0) | 1 (2.5) | NS |
| History of stroke or TIA | 8 (17.4) | 4 (66.7) | 4 (10) | .005 |
| Occlusion site (No.) (%) | ||||
| Middle cerebral artery | 26 (56.5) | 5 (83.3) | 21 (52.5) | NS |
| Internal carotid artery | 8 (17.4) | 0 (0) | 8 (20) | NS |
| Basilar artery | 12 (26.1) | 1 (16.7) | 11 (27.5) | NS |
| Baseline NIHSS score (IQR) | 12 (8–14) | 9.5 (6.5–14.5) | 10 (9–14) | NS |
| Intravenous thrombolysis (No.) (%) | 18 (39.1) | 4 (66.7) | 14 (35) | NS |
| Intra-arterial thrombolysis (No.) (%) | 7 (15.2) | 1 (16.7) | 6 (15) | NS |
| Time to procedure (min) (IQR) | 270 (207.75–362) | 277.5 (233.75–330.00) | 252.5 (187.5–360) | NS |
| Procedural time (min) (IQR) | 36 (25–46.75) | 33 (22.75–47.25) | 37 (25.75–48.75) | NS |
| Time to revascularization (min) (IQR) | 319.5 (231.75–401.5) | 305 (264.75–385.75) | 301 (217.5–407) | NS |
| Postprocedural residual stenosis (%) (IQR) | 25 (19.5–35.0) | 56 (42.3–71.3) | 25 (19–33) | 0.009 |
| Postprocedural antiplatelet therapy (No.) (%) | 41 (89.1) | 6 (100) | 35 (87.5) | NS |
Note:—CAD indicates coronary artery disease; NS, not significant.